Staphylococcus aureus and Streptococcus agalactiae are some of the most predominant bacteria that cause mastitis in dairy cattle. The condition reduces milk production and increases somatic cell count in milk. Mastitis detection kits, antibiotics, teat sealants, vaccines, and other therapeutics are used for preventing and treating bovine mastitis.
The global Bovine Mastitis Market is estimated to be valued at US$ 1497.52 Mn in 2023 and is expected to exhibit a CAGR of 5.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
Rising global demand for dairy products is a key driver of the bovine mastitis market. As per Food and Agriculture Organization (FAO), the per capita consumption of milk is steadily increasing globally creating the need for higher milk production. Bovine mastitis adversely impacts milk production, therefore its prevention and treatment assume significance. Furthermore, growing awareness regarding animal health and economic losses due to mastitis is prompting cattle farmers and dairy companies to focus on effective prevention and control of bovine mastitis. Development of novel veterinary drugs and vaccines for mastitis prevention is anticipated to present lucrative opportunities over the forecast period.
Segment Analysis
Therapeutics include antibiotics like ceftiofur, penicillin, and novobiocin that are primarily used for the treatment of bovine mastitis. Antibiotics remain the first line of defense for treating mastitis as they are easy to administer and show quick symptomatic relief.
PEST Analysis
Political: Regulations regarding the prudent use of antibiotics in food-producing animals are becoming stricter globally, which is forcing companies to invest more in advanced therapeutic formulations and alternatives to antibiotics.
Economic: Growth of the global dairy industry is driving increased demand for treatment and control of mastitis in dairy cattle. Losses due to mastitis amount to billions annually necessitating more effective prevention and control.
Social: Rising health consciousness among consumers about antibiotic residues in milk is propelling research into alternative treatment options like bacteriophages and homoeopathic remedies for mastitis.
Technological: Innovation in rapid detection tests, advanced intra-mammary infusions, and automatic milking systems integrated with activity monitoring can aid faster diagnosis and treatment of mastitis.
Key Takeaways
The Global Bovine Mastitis Market Size is expected to witness high growth, exhibiting CAGR of 5.2% over the forecast period, due to increasing dairy production worldwide and losses associated with mastitis. The market size for 2023 is estimated to be US$ 1497.52 Mn.
North America dominates the global bovine mastitis market owing to stringent dairy farming standards and growing dairy consumption in the region. However, Asia Pacific is expected to witness the highest growth over the forecast period led by rising milk output, increasing herd size, and growing meat consumption in China and India.
Key players operating in the bovine mastitis market are Zoetis, Merck & Co., Inc., Boehringer Ingelheim International GmbH, Bayer AG, Elanco, Ceva, West Way Health, Norbrook, DeLaval, ImmuCell Corporation, Advanced Animal Diagnostics, and Nimrod Veterinary Products Ltd. Major players are focusing on expanding their product portfolios with mastitis prevention products like teat dips and vaccines in addition to therapeutics.
Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
